Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines

BACKGROUND: Understanding immunogenicity and effectiveness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is critical to guide rational use. METHODS: We compared the immunogenicity of mRNA-1273, BNT-162b2, and Ad26.COV2.S in healthy ambulatory adults. We performed an invers...

Descripción completa

Detalles Bibliográficos
Autores principales: Naranbhai, Vivek, Garcia-Beltran, Wilfredo F, Chang, Christina C, Berrios Mairena, Cristhian, Thierauf, Julia C, Kirkpatrick, Grace, Onozato, Maristela L, Cheng, Ju, St Denis, Kerri J, Lam, Evan C, Kaseke, Clarety, Tano-Menka, Rhoda, Yang, Diane, Pavlovic, Maia, Yang, Wendy, Kui, Alexander, Miller, Tyler E, Astudillo, Michael G, Cahill, Jennifer E, Dighe, Anand S, Gregory, David J, Poznansky, Mark C, Gaiha, Gaurav D, Balazs, Alejandro B, Iafrate, A John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689763/
https://www.ncbi.nlm.nih.gov/pubmed/34888672
http://dx.doi.org/10.1093/infdis/jiab593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689763/
https://www.ncbi.nlm.nih.gov/pubmed/34888672
http://dx.doi.org/10.1093/infdis/jiab593

Ejemplares similares